Amkor Technology Operating Cash Flow decreased by 77.5% to $145.09M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 500.8%, from $24.15M to $145.09M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -0.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $279.54M | $175.29M | $489.68M | $166.18M | $296.09M | $83.50M | $552.99M | $175.75M | $246.83M | $273.61M | $573.83M | $162.31M | $224.76M | $164.19M | $537.61M | $24.15M | $258.46M | $168.51M | $644.48M | $145.09M |
| QoQ Change | — | -37.3% | +179.4% | -66.1% | +78.2% | -71.8% | +562.3% | -68.2% | +40.4% | +10.8% | +109.7% | -71.7% | +38.5% | -26.9% | +227.4% | -95.5% | +970.3% | -34.8% | +282.4% | -77.5% |
| YoY Change | — | — | — | — | +5.9% | -52.4% | +12.9% | +5.8% | -16.6% | +227.7% | +3.8% | -7.6% | -8.9% | -40.0% | -6.3% | -85.1% | +15.0% | +2.6% | +19.9% | +500.8% |